Remote Patient Monitoring Devices Market, by Product Type (Cardiac Monitors, Respiratory Monitors, Hematological Monitors, and Others), by Application (Cardiac Arrhythmia, Diabetes, Ischemic Disease, Hypertension, Sleep Apnea, Chronic Respiratory Diseases

Remote Patient Monitoring Devices Market, by Product Type (Cardiac Monitors, Respiratory Monitors, Hematological Monitors, and Others), by Application (Cardiac Arrhythmia, Diabetes, Ischemic Disease, Hypertension, Sleep Apnea, Chronic Respiratory Diseases, and Hyperlipidemia), by End User (Hospitals, Home Care Settings, Long-term Care Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Remote patient monitoring devices supports patient monitoring of vital signs (heart rate, blood pressure and others) without visiting medical practitioner. This devices are used to monitor patients, gathers medical data, and securely pass the data to the healthcare providers at other location for clinical review. The remote patient monitoring devices helps to control patient healthcare expenditure by reducing hospital stays, encourages patients to shift to self-care and avoid hospital readmissions, with reliable diagnosis.
These remote patient monitoring devices allow real-time sharing that allows physicians to take vital decisions to ensure efficient treatment for various physiological parameters. These devices also increase patient engagement and allow patients to manage and understand their own health conditions.
Market Dynamics
Increasing adoption of patient monitoring devices has led to increasing number of product innovations and launches of patient monitoring devices, which is expected to drive the global remote patient monitoring devices market growth over the forecast period. For instance, in March 2019, VivaLNK a provider of connected healthcare solutions launched its internet on things enabled medical wearable sensor platform (VivaLNK sensor platform). The platform has a range of sensors, edge computing technologies, and an Internet of Health Things (IoHT) data cloud. This platform captures human body information through biometrics, and delivers data of patient to computing devices and cloud software.
Key players are focused on adopting inorganic strategies such as mergers and acquisitions to expand their products offerings and strengthen their market position. For instance, in April 2019, Smith & Nephew acquired Leaf Healthcare, a patient monitoring system developer. Moreover, in September 2019, Baxter International Inc., a medical products company, entered into an agreement to acquire Cheetah Medical, a provider of non-invasive hemodynamic monitoring technologies to expand Baxter International Inc.’s specialized patient monitoring portfolio. This is expected to drive the global remote patient monitoring devices market growth.
Increasing prevalence of chronic diseases is expected to propel the global remote patient monitoring devices market growth. For instance, according to the International Diabetes Federation (IDF) in 2017, approximately 425 million people aged (20-79 years) suffered from diabetes globally, of which 4 million people were reported to die due to diabetes. Moreover, according to the World Health Organization (WHO) September 2019, about 1.13 billion people suffer from hypertension globally. Increasing prevalence of such health conditions is expected to boost the global remote patient monitoring devices market growth over the forecast period.
Key features of the study:
This report provides in-depth analysis of the remote patient monitoring devices market and its application, market size (US$ Million) and cumulative annual growth rate (CAGR (%)) for the forecast period (2022 - 2028), considering 2021 as the base year.
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or product approvals, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global remote patient monitoring devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Abbott Laboratories, GE Healthcare, Omron Healthcare, Medtronic PLC., Nihon Kohden, Smiths Medical, Philips Healthcare, F. Hoffmann-La Roche Ltd., Koninklijke Philips N.V., and St. Jude Medical.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, end user upgrades, market expansion, and marketing tactics
The global remote patient monitoring devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Detailed Segmentation:
Global Remote Patient Monitoring Devices Market, By Product Type:
Cardiac Monitors
Respiratory Monitors
Hematological Monitors
Others
Global Remote Patient Monitoring Devices Market, By Application:
Cardiac Arrhythmia
Diabetes
Ischemic Diseases
Hypertension
Sleep Apnea
Chronic Respiratory Diseases
Hyperlipidemia
Global Remote Patient Monitoring Devices Market, By End User:
Hospitals
Home Care Settings
Long-term Care Centers
Others
Global Remote Patient Monitoring Devices Market, By Region:
North America
Product Type:
Cardiac Monitors
Respiratory Monitors
Hematological Monitors
Others
By Application:
Cardiac Arrhythmia
Diabetes
Ischemic Diseases
Hypertension
Sleep Apnea
Chronic Respiratory Diseases
Hyperlipidemia
By End User:
Hospitals
Home Care Settings
Long-term Care Centers
Others
By Country:
U.S.
Canada
Europe
Product Type:
Cardiac Monitors
Respiratory Monitors
Hematological Monitors
Others
By Application:
Cardiac Arrhythmia
Diabetes
Ischemic Diseases
Hypertension
Sleep Apnea
Chronic Respiratory Diseases
Hyperlipidemia
By End User:
Hospitals
Home Care Settings
Long-term Care Centers
Others
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Product Type:
Cardiac Monitors
Respiratory Monitors
Hematological Monitors
Others
By Application:
Cardiac Arrhythmia
Diabetes
Ischemic Diseases
Hypertension
Sleep Apnea
Chronic Respiratory Diseases
Hyperlipidemia
By End User:
Hospitals
Home Care Settings
Long-term Care Centers
Others
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Product Type:
Cardiac Monitors
Respiratory Monitors
Hematological Monitors
Others
By Application:
Cardiac Arrhythmia
Diabetes
Ischemic Diseases
Hypertension
Sleep Apnea
Chronic Respiratory Diseases
Hyperlipidemia
By End User:
Hospitals
Home Care Settings
Long-term Care Centers
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Product Type:
Cardiac Monitors
Respiratory Monitors
Hematological Monitors
Others
By Application:
Cardiac Arrhythmia
Diabetes
Ischemic Diseases
Hypertension
Sleep Apnea
Chronic Respiratory Diseases
Hyperlipidemia
By End User:
Hospitals
Home Care Settings
Long-term Care Centers
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
Product Type:
Cardiac Monitors
Respiratory Monitors
Hematological Monitors
Others
By Application:
Cardiac Arrhythmia
Diabetes
Ischemic Diseases
Hypertension
Sleep Apnea
Chronic Respiratory Diseases
Hyperlipidemia
By End User:
Hospitals
Home Care Settings
Long-term Care Centers
Others
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
Abbott Laboratories *
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Future Plans
GE Healthcare
Omron Healthcare
Medtronic PLC.
Nihon Kohden
Smiths Medical
Philips Healthcare
F. Hoffmann-La Roche Ltd.
Koninklijke Philips N.V.
St. Jude Medical
“*” marked represents similar segmentation in other categories in the respective section